The largest database of trusted experimental protocols

Naloxone hydrochloride

Manufactured by Fujifilm
Sourced in Japan

Naloxone hydrochloride is a synthetic opioid antagonist used in laboratory settings. It works by blocking or reversing the effects of opioid medications, including respiratory depression and sedation. Naloxone hydrochloride is commonly used in research and development to study the pharmacological properties of opioid drugs.

Automatically generated - may contain errors

4 protocols using naloxone hydrochloride

1

Solubilizing Reagents for Biochemical Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sodium butyrate (SB; Fujifilm Wako Pure Chemical Corporation, Osaka, Japan) was dissolved in phosphate-buffered saline (PBS; 0.14 M NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 1.8 mM KH2PO4). LPS obtained from Escherichia coli with serotype 055:B5 (Sigma-Aldrich, St. Louis, MO, USA), a rat/human CRF (Peptide Institute, Inc., Asagi, Japan), NG-nitro-L-arginine methyl ester (L-NAME), naloxone hydrochloride and domperidone (Fujifilm Wako Pure Chemical) were dissolved in normal saline. Compound C (dorsomorphin; LC Laboratories, Inc., Woburn, MA, USA), GW9662 (Focus Biomolecules, Plymouth Meeting, PA, USA) and sulpiride (Fujifilm Wako Pure Chemical) were dissolved in dimethyl sulfoxide (Fujifilm Wako Pure Chemical). The doses and routes of administration of the chemicals were determined according to previous publications5 (link),6 (link),17 (link)–20 (link).
+ Open protocol
+ Expand
2

Spinal Cord Slice Remifentanil Perfusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drugs were dissolved in Krebs solution and applied by perfusion via a three-way stopcock without any change in either the perfusion rate or the temperature. The drugs used in this study were Ultiva®, 2 mg (Janssen Pharmaceutical K.K., Tokyo, Japan), TTX (Wako, Osaka, Japan), glycine (Wako) and naloxone hydrochloride (Wako). All drugs were diluted to their final concentration in Krebs solution immediately before use. A 2-mg Ultiva® vial contains 15 mg glycine as an adjunct. Ultiva® containing 50 μM remifentanil hydrochloride with 2 mM glycine was superfused on to spinal cord slice preparations in vivo and ex vivo. The plasma concentration of remifentanil achieved by an intravenous infusion of Ultiva® at 0.05–0.20 μg·kg−1 min−1 is approximately 1–5 ng/ml [14 (link), 15 (link)]. Remifentanil has a rapid blood-brain equilibration half-time because of its rapid onset of action. Although the transit of remifentanil to the cerebrospinal fluid is not completely understood, the concentration of Ultiva® superfused was not determined from the plasma concentration, but from the effect obtained in a previous study of Ultiva® or pure remifentanil [5 (link), 16 (link)].
+ Open protocol
+ Expand
3

Neuroinflammation Modulation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
LPS obtained from Escherichia coli with the serotype 055:B5 (Sigma-Aldrich, St.
Louis, MO, USA); naloxone hydrochloride, an opioid receptor antagonist; N G -nitro-Larginine methyl ester (L-NAME), a nitric oxide (NO) synthesis inhibitor (Wako Pure Chemical Industries, Osaka, Japan) and mevalonolactone (Tokyo Chemical Industry, Tokyo, Japan) were dissolved in normal saline. Lovastatin (Tokyo Chemical Industry) was dissolved in dimethyl sulfoxide (Sigma-Aldrich). The chemical doses were determined according to previous studies (Mirhadi, 2011; Nozu et al., 2017a; Nozu et al., 2017b) .
+ Open protocol
+ Expand
4

DHEA-S and CRF Receptor Antagonism

Check if the same lab product or an alternative is used in the 5 most similar protocols
DHEA-S sodium hydrate (Tokyo Chemical Industry, Tokyo, Japan), LPS obtained from Escherichia coli with the serotype 055:B5 (Sigma-Aldrich, St. Louis, MO, USA), rat/human CRF (Peptide Institute Inc., Asagi, Japan), N G -nitro-L-arginine methyl ester (L-NAME), a nitric oxide (NO) synthesis inhibitor, naloxone hydrochloride, an opioid receptor antagonist and domperidone (Wako Pure Chemical Industries, Osaka, Japan), a peripheral dopamine D2 receptor antagonist were dissolved in normal saline. Sulpiride (Wako Pure Chemical Industries), a dopamine D2 receptor antagonist and bicuculline (Sigma-Aldrich), a γ-aminobutyric acid (GABA)A receptor antagonist was dissolved in saline containing 10 % dimethyl sulfoxide (DMSO). Astressin2-B, a selective CRF receptor subtype 2 (CRF2) antagonist (Sigma-Aldrich) was dissolved in double-distilled water. The doses of the chemicals were determined according to the previous reports (Nozu et al., 2017a (Nozu et al., , 2019;; Nozu et al., 2017b; Samardzic et al., 2017) .
The volume of injection was 0.2 ml/rat. DHEA-S, L-NAME, CRF or Astressin2-B was intraperitoneally injected. Other chemicals were administered via subcutaneous route.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!